Betulinic acid and apoptosis-involved pathways: Unveiling its bidirectional regulatory role
Open Access
- 20 November 2025
- journal article
- review article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 1008, 178361
Abstract
No abstract availableKeywords
Funding Information
- Medical Science and Technology Project of Zhejiang Province (2025ZR152)
- Zhejiang Province Natural Science Foundation (LYQ20H280002)
This publication has 166 references indexed in Scilit:
- Suppression of lncRNA MALAT1 by betulinic acid inhibits hepatocellular carcinoma progression by targeting IAPs via miR‐22‐3pClinical and Translational Medicine, 2020
- The molecular details of cytokine signaling via the JAK/STAT pathwayProtein Science, 2018
- Effects and mechanisms of betulinic acid on improving EGFR TKI‐resistance of lung cancer cellsEnvironmental Toxicology, 2018
- Mechanisms of DNA damage, repair, and mutagenesisEnvironmental and Molecular Mutagenesis, 2017
- Betulinic Acid and its Derivatives as Potential Antitumor AgentsMedicinal Research Reviews, 2015
- PI3K target based novel cyano derivative of betulinic acid induces its signalling inhibition by down-regulation of pGSK3β and cyclin D1 and potentially checks cancer cell proliferationMolecular Carcinogenesis, 2015
- Betulinic acid decreases ER‐negative breast cancer cell growth in vitro and in vivo: Role of Sp transcription factors and microRNA‐27a:ZBTB10Molecular Carcinogenesis, 2012
- Betulinic acid suppresses STAT3 activation pathway through induction of protein tyrosine phosphatase SHP‐1 in human multiple myeloma cellsInternational Journal of Cancer, 2009
- Oxidative stress and apoptosis: Impact on cancer therapyJournal of Pharmaceutical Sciences, 2007
- Signalling responses linked to betulinic acid‐induced apoptosis are antagonized by MEK inhibitor U0126 in adherent or 3D spheroid melanoma irrespective of p53 statusInternational Journal of Cancer, 2005